Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can simple breathing exercises calm pregnancy anxiety in slum communities?

NCT ID NCT07787000

Symptom relief Sponsor: Bahria University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This trial tests whether a program called BreLax, which includes breathing exercises, muscle relaxation, and guided relaxation, can reduce anxiety in pregnant women living in urban slums of Karachi. Pregnant women aged 18-40 will be randomly assigned to receive routine care, structured education, BreLax exercises, or a combination. The study measures anxiety levels and childbirth experiences at several points during and after pregnancy to see if these low-cost techniques offer meaningful relief.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
BreLax, a behavioral intervention combining breathing exercises, progressive muscle relaxation, and guided relaxation, with or without structured midwife-led education
What this could lead to
If effective, BreLax could offer a low-cost, culturally adapted way to ease anxiety and improve childbirth experiences for pregnant women in underserved communities.
What could go wrong
This is a relatively small, early-stage trial in a specific urban slum setting, so results may not apply broadly. The intervention's success depends on adherence and may not significantly reduce anxiety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 255 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 49 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant women aged between 18 and 40 years * with a gestational age of 12 to 28 weeks at recruitment * residing in selected slum areas of Karachi * willing to participate by providing informed consent will be eligible for inclusion * women with a history of intrauterine death or stillbirths will be considered Exclusion Criteria: * Women will be excluded if they have a diagnosed psychiatric illness requiring medical treatment * high-risk pregnancy complications such as pre-eclampsia or severe anemia * if they are already practicing structured relaxation techniques or psychological interventions * Those unable to communicate in Urdu or the local language * women with recurrent pregnancy loss, those already on antipsychotic or anti-anxiety medications * women who screen positive on the Fear of Birth Scale will also be excluded from participation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Perinatal anxiety are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Perinatal anxiety

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.